VivoSim Labs, Inc.
VIVS
Price:
$2.29
Market Cap:
$5.97M
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus steatohepatitis. Org...[Read more]
Industry
Biotechnology
IPO Date
2012-02-14
Stock Exchange
NASDAQ
Ticker
VIVS
PE Ratio
[4.49]
ROE
[-33.01%]
Current Ratio
[4.52]
Dividend Yield
[0%]
Enterprise Value
[-2260767.00]
Dividend History
The ROE as of December 2025 (TTM) for VivoSim Labs, Inc. (VIVS) is -33.01%
According to VivoSim Labs, Inc.’s latest financial reports and current stock price. The company's current ROE is -33.01%. This represents a change of -86.53% compared to the average of -245.19% of the last 4 quarters.
VivoSim Labs, Inc. (VIVS) Historical ROE (quarterly & annually)
How has VIVS ROE performed in the past?
The mean historical ROE of VivoSim Labs, Inc. over the last ten years is -96.99%. The current -33.01% ROE has changed -65.96% with respect to the historical average. Over the past ten years (40 quarters), VIVS's ROE was at its highest in in the March 2025 quarter at 65.31%. The ROE was at its lowest in in the December 2024 quarter at -946.98%.
Average
-96.99%
Median
-66.15%
Minimum
-407.41%
Maximum
-23.71%
VivoSim Labs, Inc. (VIVS) ROE by Quarter and Year
Discovering the peaks and valleys of VivoSim Labs, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 261.86%
Maximum Annual ROE = -23.71%
Minimum Annual Increase = -94.18%
Minimum Annual ROE = -407.41%
| Year | ROE | Change |
|---|---|---|
| 2025 | -23.71% | -94.18% |
| 2024 | -407.41% | 261.86% |
| 2023 | -112.59% | 197.10% |
| 2022 | -37.90% | -11.72% |
| 2021 | -42.93% | -38.90% |
| 2020 | -70.26% | -4.25% |
| 2019 | -73.38% | -5.99% |
| 2018 | -78.06% | 26.61% |
| 2017 | -61.65% | -0.62% |
| 2016 | -62.04% | 0.42% |
VivoSim Labs, Inc. (VIVS) Average ROE
How has VIVS ROE performed in the past?
The current ROE of VivoSim Labs, Inc. (VIVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-181.24%
5-year avg
-124.91%
10-year avg
-96.99%
VivoSim Labs, Inc. (VIVS) ROE vs. Peers
How is VIVS’s ROE compared to its peers?
VivoSim Labs, Inc.’s ROE is greater than Quoin Pharmaceuticals, Ltd. (-210.51%), greater than Pasithea Therapeutics Corp. (-99.53%), greater than Cyclerion Therapeutics, Inc. (-24.61%), greater than Alaunos Therapeutics, Inc. (-167.97%), greater than PharmaCyte Biotech, Inc. (-2.51%), greater than Polyrizon Ltd. (-8.09%), less than NovaBay Pharmaceuticals, Inc. (117.09%), less than Radiopharm Theranostics Limited (0%), greater than XTL Biopharmaceuticals Ltd. (-33.89%), greater than Impact BioMedical Inc. (-528.69%),
| Company | ROE | Market cap |
|---|---|---|
| -210.51% | $11.12M | |
| -99.53% | $8.63M | |
| -24.61% | $5.67M | |
| -167.97% | $8.01M | |
| -2.51% | $8.22M | |
| -8.09% | $14.21M | |
| 117.09% | $6.55M | |
| 0% | $5.91M | |
| -33.89% | $4.76M | |
| -528.69% | $5.88M |
Build a custom stock screener for VivoSim Labs, Inc. (VIVS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VivoSim Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
VivoSim Labs, Inc. (VIVS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like VivoSim Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is VivoSim Labs, Inc.'s ROE?
How is the ROE calculated for VivoSim Labs, Inc. (VIVS)?
What is the highest ROE for VivoSim Labs, Inc. (VIVS)?
What is the 3-year average ROE for VivoSim Labs, Inc. (VIVS)?
What is the 5-year average ROE for VivoSim Labs, Inc. (VIVS)?
How does the current ROE for VivoSim Labs, Inc. (VIVS) compare to its historical average?